White label ELPA - ClinicalTrials.eu

Testing the Safety of Combining Tocilizumab with Other Biologic Drugs in Patients with Rheumatoid Arthritis or Psoriatic Arthritis

Not yet recruiting

2 1 1 1
Investigated diseases:
- Psoriatic arthropathy
- Rheumatoid arthritis
Investigated drugs:
- Tocilizumab
Study of rituximab followed by cladribine for patients with relapsing-remitting multiple sclerosis with less than 10 years disease duration

Not yet recruiting

2 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
Study of Rituximab Treatment for Women with Autoimmune Premature Ovarian Insufficiency to Improve Fertility

Not yet recruiting

3 1 1 1
Investigated diseases:
- Infertility female
Investigated drugs:
- Rituximab
Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

Not yet recruiting

2 1 1 1
Investigated diseases:
- Relapsing-remitting multiple sclerosis
- Multiple sclerosis
Investigated drugs:
Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

Not yet recruiting

2 1 1
Investigated diseases:
- Partial seizures
Study of Citicoline to Prevent Cognitive Decline After Delirium in Older Adults with Hip Fracture

Not yet recruiting

2 1 1 1
Investigated diseases:
- Cognitive disorder
Study of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer

Not yet recruiting

3 1 1 1
Investigated diseases:
- Nasopharyngeal cancer
Investigated drugs:
Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment

Not yet recruiting

2 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
+3
Study comparing fluticasone furoate and vilanterol inhalation powder with BREO ELLIPTA in adults with asthma to evaluate their therapeutic equivalence and safety

Not yet recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

Not yet recruiting

2 1 1
Investigated drugs:
- VG801-1
- VG801-2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies